Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
基本信息
- 批准号:10229419
- 负责人:
- 金额:$ 33.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnabolismAnteriorBehaviorBindingCellsCharacteristicsDataDiseaseEndotheliumExtracellular MatrixExtracellular Matrix ProteinsEyeFundingGlaucomaHomeostasisHumanKnowledgeMechanicsMessenger RNAMolecularOrgan Culture TechniquesOutcome StudyPathway interactionsPeptidesPerfusionPhysiologic Intraocular PressureProcessProtein BiosynthesisProtein OverexpressionProteomicsRNA InterferenceRegulationResistanceRisk FactorsRoleStretchingStructure of sinus venosus of scleraTestingTherapeuticTissuesTrabecular meshwork structureaqueousfunctional restorationinhibitor/antagonistknock-downlaser capture microdissectionmRNA Expressionmolecular subtypesnovelpressureprotein expressionprotein functionresponse
项目摘要
Project Summary
Glaucoma is a major blinding disease. The primary risk factor and only current treatment target for all types of
glaucoma is elevated intraocular pressure (IOP). We have identified a robust IOP homeostatic mechanism in
which sustained pressure deviations are sensed as mechanical stretching/distortion by cells within the
juxtacanalicular (JCT) region of the outflow pathway and corrective adjustments are made to the outflow
resistance which restore IOP to appropriate levels. This appears to be a key reason that most people do not
develop glaucoma. We recently showed that glaucomatous anterior segments cannot execute a normal IOP
homeostatic response. Outflow is segmental around the circumference of the eye with regions of high flow (HF)
intermediate flow (IF) and low flow (LF). We recently showed that glaucomatous eyes have more LF regions
than normal eyes. This proposal is directed at understanding these two phenomena, IOP homeostasis and
outflow segmentation, and exploiting this understanding to correct the glaucomatous deficiencies in them.
To begin understanding the IOP homeostatic process and outflow segmentation, we evaluated molecular
distribution differences between HF and LF regions of human anterior segments that had been perfused at 1x
(normal) or 2x (homeostatic response) pressures. We selected a subset of the molecular differences that seemed
most relevant to these processes; they were mostly extracellular matrix (ECM) proteins that function in ECM
organization and remodeling. We will refine their distributions, evaluate their regional biosynthesis/dynamics
rates, use RNAi silencing to knockdown their levels, interfere directly with their binding interactions, and conduct
a few select protein overexpression studies. Primary readouts will be outflow segmentation changes and outflow
facility changes in perfused human anterior segment organ culture. Next we will obtain the same molecular
distribution data for glaucomatous eyes and using the most effective RNAi silencing and binding interaction
perturbations from normal and apply them to glaucomatous eyes. The point will be to modify outflow
segmentation and IOP homeostatic responsiveness in diseased tissue to restore function.
项目摘要
青光眼是一种主要的致盲性疾病。所有类型的主要风险因素和唯一的当前治疗目标
青光眼是眼内压(IOP)升高。我们已经确定了一个强大的IOP稳态机制,
所述持续的压力偏差被感测为细胞内的机械拉伸/变形
流出道的前小管(JCT)区域,并对流出道进行校正调整
使IOP恢复到适当水平的阻力。这似乎是大多数人不这样做的关键原因。
患上青光眼。我们最近发现,青光眼的眼前节不能执行正常的眼压,
稳态反应外流是围绕眼周的节段性高流量(HF)区域
中间流量(IF)和低流量(LF)。我们最近发现,青光眼的眼睛有更多的LF区域,
比正常的眼睛。该建议旨在理解这两种现象,IOP稳态和IOP内分泌。
流出分割,并利用这种理解,以纠正他们的昏迷缺陷。
为了开始了解IOP稳态过程和流出道分割,我们评估了分子水平的
人眼前节HF和LF区域之间的分布差异,已在1x
(正常)或2倍(稳态反应)压力。我们选择了一部分分子差异,
与这些过程最相关;它们主要是在ECM中起作用的细胞外基质(ECM)蛋白
组织和重塑。我们将完善它们的分布,评估它们的区域生物合成/动态
速率,使用RNAi沉默来敲低它们的水平,直接干扰它们的结合相互作用,
一些精选的蛋白质过度表达研究。主要读数将是流出分段变化和流出
灌注的人眼前节器官培养中的设施变化。接下来我们将获得相同的分子
分布数据,并使用最有效的RNAi沉默和结合相互作用
从正常的扰动,并将其应用到昏迷的眼睛。关键是要改变外流
分割和IOP稳态响应以恢复功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TED S ACOTT其他文献
TED S ACOTT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TED S ACOTT', 18)}}的其他基金
Mechanotransduction in Aqueous Outflow Regulation and Open Angle Glaucoma
房水流出调节和开角型青光眼中的机械传导
- 批准号:
10091442 - 财政年份:2018
- 资助金额:
$ 33.61万 - 项目类别:
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
8943562 - 财政年份:2015
- 资助金额:
$ 33.61万 - 项目类别:
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
10004627 - 财政年份:2015
- 资助金额:
$ 33.61万 - 项目类别:
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
9115612 - 财政年份:2015
- 资助金额:
$ 33.61万 - 项目类别:
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
流出分段和眼压稳态的分子机制
- 批准号:
10478291 - 财政年份:2015
- 资助金额:
$ 33.61万 - 项目类别:
相似海外基金
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10590611 - 财政年份:2022
- 资助金额:
$ 33.61万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
- 批准号:
10706006 - 财政年份:2022
- 资助金额:
$ 33.61万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10368975 - 财政年份:2021
- 资助金额:
$ 33.61万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10365254 - 财政年份:2021
- 资助金额:
$ 33.61万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10202896 - 财政年份:2021
- 资助金额:
$ 33.61万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10531570 - 财政年份:2021
- 资助金额:
$ 33.61万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10541847 - 财政年份:2019
- 资助金额:
$ 33.61万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10319573 - 财政年份:2019
- 资助金额:
$ 33.61万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10062790 - 财政年份:2019
- 资助金额:
$ 33.61万 - 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
- 批准号:
DE170100628 - 财政年份:2017
- 资助金额:
$ 33.61万 - 项目类别:
Discovery Early Career Researcher Award














{{item.name}}会员




